Cart
sales@molnova.com
FEN1-IN-3
CAS No. 2109805-87-8
FEN1-IN-3( —— )
Catalog No. M37614 CAS No. 2109805-87-8
FEN1-IN-3 is a human flap endonuclease-1 ( hFEN1 ) inhibitor that stabilizes hFEN1 with an EC 50 of 6.8 μM .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 51 | In Stock |
|
| 25MG | 91 | In Stock |
|
| 50MG | 145 | In Stock |
|
| 100MG | 243 | In Stock |
|
| 200MG | 338 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFEN1-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionFEN1-IN-3 is a human flap endonuclease-1 ( hFEN1 ) inhibitor that stabilizes hFEN1 with an EC 50 of 6.8 μM .
-
DescriptionFEN1-IN-3 (Compound 4) is a human flap endonuclease-1 (hFEN1) inhibitor. FEN1-IN-3 stabilizes hFEN1 with an EC50 of 6.8 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2109805-87-8
-
Formula Weight284.27
-
Molecular FormulaC15H12N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (879.45 mM; Ultrasonic )
-
SMILESCOc1ccc(cc1)-n1c2ccccc2c(=O)n(O)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jack C Exell, et al. Cellularly Active N-hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site. Nat Chem Biol. 2016 Oct;12(10):815-21.?
molnova catalog
related products
-
ciscis-Muconic acid
ciscis-Muconic acid is a naturally-occurring organic acid. It is used in the manufacture of several widely-used consumer plastics. Its microbial production via extending the shikimate pathway has been reported.
-
Minecoside
Minecoside exhibits potent antioxidant activity.
-
Retinyl propionate
Vitamin A Propionate is an ester compound of vitamin A. In nutritional studies of foals, different doses have different effects on growth, serum biochemistry and hematological indicators. Too high or too low doses will produce adverse effects and are related to the vitamin A concentration in plasma, liver and kidneys.
